NCT00812240 2023-02-01Masitinib in First Line Treatment of Gastro-Intestinal Stromal Tumor (GIST)AB SciencePhase 3 Terminated335 enrolled
NCT01694277 2020-12-08Masitinib in Patients With Gastrointestinal Stromal Tumour After Progression With ImatinibAB SciencePhase 3 Completed258 enrolled